In our study, we found that CCL2 circulating levels correlated significantly with the tumor presence and with the abundance of Fusobacterium nucleatum, Bacteroides fragilis and Gemella haemolysans in the colon of our CRC patients. The gene discussed is CCL2; the disease is colorectal carcinoma.